Lodelcizumab
Lodelcizumab (LGT 209) is a monoclonal antibody targeting the preprotein convertase Bacillus subtilis protease Kexin-9 (PCSK9) and is used to study hypercholesterolemia.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
1355338-54-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![FMOD Antibody (C-term) [APR32674G]](https://cdn.genprice.uk/genprice/genprice5.png)
![FMOD Antibody (C-term) [APR32674G]](https://cdn.genprice.uk/genprice/genprice2.png)
